Denmark· DK-28106899923

Alhemo

A concizumab product containing concizumab, registered in Denmark by Novo Nordisk A/S. The same ATC class is registered in 11 of our 19 countries.

ATC B02BX10

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedAlhemoATCB02BX10REGISTER NO.DK-28106899923PACKS LISTED1CHECKEDSeptember 30, 2026

Where it is registered

Concizumab is registered in 11 of 19 countries.

Countries holding a registration under ATC B02BX10 (concizumab), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 8 of them publish a price we can compare per daily dose

Concizumab · ATC B02BX10

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of concizumab costs, country by country.

Normalised to the WHO defined daily dose (14 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Concizumab · price per daily dose (14 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1227.21
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
Concizumab
Manufacturer
Novo Nordisk A/S
Country
Denmark (DK)
ATC code
B02BX10
ATC class
Concizumab
Defined daily dose
14 mg, P
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28106899923

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ea0293c0-b15a-4709-89e7-6f3fe5a8fd30
GET /v1/drugs/ea0293c0-b15a-4709-89e7-6f3fe5a8fd30?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "injektionsvæske, opløsning i fyldt pen",
  "source": "dkma",
  "strength": "300 mg/3 ml",
  "auth_role": "MOD",
  "dk_drugid": "28106899923",
  "substance": "Concizumab",
  "auth_procedure": "Central",
  "in_medicinpriser": false,
  "registration_date_serial": "45639"
}

See everything about concizumab.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.